“We gave the mice a blocker of all caspases [pancaspase inhibitor], a compound known as Q-VD-OPH, thinking it would leave both sets of mice more vulnerable to MRSA infection,” Miller says. “To our surprise, blocking caspases had the opposite effect, resulting in a rapid and remarkable clearing of the MRSA bacteria by keeping the immune cells alive and boosting their protective function.”
Sensing they might have accidentally uncovered a means of fighting bacterial “superbugs,” Miller and his colleagues conducted their latest study to confirm the unexpected finding was not a fluke.
The results were encouraging.
“A single oral dose of Q-VD-OPH decreased the size of MRSA skin lesions and rapidly cleared the bacteria compared with vehicle-treated [given the carrier solution without Q-VD-OPH] and untreated mice,” says study lead author Martin Alphonse, Ph.D., a dermatology postdoctoral fellow at the Johns Hopkins University School of Medicine. “And surprisingly, the treatment worked whether IL-1β was present or not—and without administering any antibiotics.”
- Insane Vid — Man Stream Admission he Killed His Ex-Girlfriend as he prepares to Kill Ex-Wife
- Bannon: Audits Will Happen in Georgia
- Stolen Motorcycle Crashes at 130mph On Live TV
- New Peer-Reviewed Study Shows Ivermectin ‘Significantly’ Reduces COVID Infections, Hospitalization, and Mortality
- Oh Nooooo. Rock legend Meatloaf dead at 74
- Is Gavin Newsom hiding because he got Bell’s Palsy from Booster Shot?
- Debate tournament banned White students from competing
- Sweden’s Lund University researcher faces prosecution for study that showed most rapes are committed by immigrants
- Aussie Police confirm use of controversial LRAD Weapon against Canberra protestors
- Dem Congressman Threatens to Seize Trucks if they Clog DC beltway: ‘Perfect time to impound and give the trucks to small trucking companies’